Studies Currently Enrolling Patients

For information about clinical trials that may be opening soon, please contact the Clinical Research Center by phone (207) 973-7596 or e-mail cwhited@emhs.org.

Currently Enrolling Patients:
Cardiology clinical trials are conducted at EMMC Northeast Cardiology Associates.

For information, please contact Northeast Cardiology research at (207) 275-3831.
No open studies enrolling patients at this time.
TrialNet - Natural History Study of the Development of Type 1 Diabetes.

For more information, please contact the Clinical Research Center by phone (207) 973-7596 or e-mail cwhited@emhs.org.
Micronutrients as Adjunctive Treatment for Bipolar Disorder.

For more information, please contact the Clinical Research Center by phone (207) 973-9013 or e-mail educker@emhs.org.

 
APPRENTICE: Acute Pancreatitis Patient Registry to Examine Novel Therapies in Clinical Experience.

For more information, please contact the Clinical Research Center by phone (207) 973-7596 or e-mail
cwhited@emhs.org.
 
Geriatric Psychiatry:
1) A Phase 3 Safety & Efficacy Study of ALZT-OP1 in Subjects with Early Alzheimer's Disease.


For more information, please contact the Clinical Research Center by phone (207) 973-7224 or email nvekima@emhs.org.

2) SUVEN - A Phase 2A Multicenter, Randomized, Double-blind, Parallel Group, 26-Week, Placebo-controlled Study of 50 mg and 100 mg of SUVN-502 in Subjects with Moderate Alzheimer's Disease Currently Treated with Donepezil Hydrochloride and Memantine Hydrochloride.


For more information, please contact the Clinical Research Center by phone (207) 973-4263 or email keanderson@emhs.org.

3) HARMONY - A Double-blind, Placebo-controlled, Relapse Prevention Study of Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Dementia-related Psychosis.

4) A 52-Week Open-label Extension Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects with Alzheimer's Disease.

5) Long-Term Nicotine Treatment of Mild Cognitive Impairment.

For more information, please contact the Clinical Research Center by phone (207) 973-7726 or email kchamberlain@emhs.org.


 
No open studies enrolling patients at this time.
 
No open studies enrolling patients at this time.
No open studies enrolling patients at this time.
No open studies enrolling patients at this time.
No open studies enrolling patients at this time.
1) PASSAGE:  Long-term, Prospective, Multinational, Parallel-cohort Study Monitoring Safety in Patients with MS Newly Started with Fingolimod Once Daily or Treated with Another Approved Disease-modifying Therapy.

2) Management of Parkinson's Disease Psychosis in Actual Practice (The INSYTE Study).

For more information, please contact the Clinical Research Center by phone (207) 973-9013 or email educker@emhs.org.

3) Management of Acute Stroke Patients on Treatment with New Oral Anticoagulants: Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry.

4) Mild and Rapidly Improving Stroke Study (MaRISS).


For more information, please contact the Clinical Research Center by phone (207) 973-7224 or email nvekima@emhs.org.


 
1) Music in the Operating Room -- A Randomized Controlled Trial Investigating the Impact of Music on Post-operative Pain and Opioid Use.

For more information, contact the Clinical Research Center by phone at (207) 973-7596 or by e-mail to
cwhited@emhs.org.

2) A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in combination with Estradiol/Norethinddrone Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain.


For more information, contact the Clinical Research Center by phone at (207) 973-7726 or by e-mail to kmchamberlain@emhs.org.
 
Oncology research is conducted at EMMC CancerCare.

For information, please contact the Cancer Center at (207) 973-7478.
No open studies enrolling patients at this time.
No open studies enrolling patients at this time.
No open studies enrolling patients at this time.
No open studies enrolling patients at this time.
No open studies enrolling patients at this time.
Geriatric Psychiatry:
1) A Phase 3 Safety & Efficacy Study of ALZT-OP1 in Subjects with Early Alzheimer's Disease.

For more information, please contact the Clinical Research Center by phone (207) 973-7224 or email nvekima@emhs.org.

2) SUVEN - A Phase 2A Multicenter, Randomized, Double-blind, Parallel Group, 26-Week, Placebo-controlled Study of 50 mg and 100 mg of SUVN-502 in Subjects with Moderate Alzheimer's Disease Currently Treated with Donepezil Hydrochloride and Memantine Hydrochloride.


For more information, please contact the Clinical Research Center by phone (207) 973-4263 or email keanderson@emhs.org.

3) HARMONY - A Double-blind, Placebo-controlled, Relapse Prevention Study of Pimavanserin for the Treatment of Hallucinations and Delusions Associated with Dementia-related Psychosis.

4) A 52-Week Open-label Extension Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects with Alzheimer's Disease.

5) Long-Term Nicotine Treatment of Mild Cognitive Impairment.

For more information, please contact the Clinical Research Center by phone (207) 973-7726 or email kchamberlain@emhs.org.



 
No open studies enrolling patients at this time.
No open studies enrolling patients at this time.


 
No open studies enrolling patients at this time.
No open studies enrolling patients at this time.
No open studies enrolling patients at this time.
1) Global Registry for Endovascular Aortic Treatment (GREAT) Outcomes Evaluation.

For more information, contact the Clinical Research Center by phone (207) 973-7726 or email kchamberlain@emhs.org.


2) Post-Approval Study of Transcarotid Artery Revascularization in Patients with Significant Carotid Artery Disease (The ROADSTER 2 Study).


For more information, contact the Clinical Research Center by phone (207) 973-7224 or email nvekima@emhs.org.